686 related articles for article (PubMed ID: 25189652)
1. Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools.
Canturk KM; Ozdemir M; Can C; Öner S; Emre R; Aslan H; Cilingir O; Ciftci E; Celayir FM; Aldemir O; Özen M; Artan S
Mol Biol Rep; 2014 Dec; 41(12):8127-35. PubMed ID: 25189652
[TBL] [Abstract][Full Text] [Related]
2. Exosome-derived microRNAs contribute to prostate cancer chemoresistance.
Li J; Yang X; Guan H; Mizokami A; Keller ET; Xu X; Liu X; Tan J; Hu L; Lu Y; Zhang J
Int J Oncol; 2016 Aug; 49(2):838-46. PubMed ID: 27278879
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
4. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
[TBL] [Abstract][Full Text] [Related]
5. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
7. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
8. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
9. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
11. Identification of Hub Genes Associated with Hypertension and Their Interaction with miRNA Based on Weighted Gene Coexpression Network Analysis (WGCNA) Analysis.
Li Z; Chyr J; Jia Z; Wang L; Hu X; Wu X; Song C
Med Sci Monit; 2020 Sep; 26():e923514. PubMed ID: 32888289
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.
Yerukala Sathipati S; Tsai MJ; Shukla SK; Ho SY; Liu Y; Beheshti A
Sci Rep; 2022 Mar; 12(1):4141. PubMed ID: 35264666
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
Qin X; Song Y
Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
[TBL] [Abstract][Full Text] [Related]
15. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
[TBL] [Abstract][Full Text] [Related]
16. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics prediction and experimental validation of a novel microRNA: hsa-miR-B43 within human CDH4 gene with a potential metastasis-related function in breast cancer.
Rahimi A; Sedighi R; Emadi-Baygi M; Honardoost MA; Mowla SJ; Khanahmad H; Nikpour P
J Cell Biochem; 2020 Feb; 121(2):1307-1316. PubMed ID: 31489987
[TBL] [Abstract][Full Text] [Related]
19. Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer.
Lin GB; Zhang CM; Chen XY; Wang JW; Chen S; Tang SY; Yu TQ
Math Biosci Eng; 2019 Nov; 17(1):834-844. PubMed ID: 31731380
[TBL] [Abstract][Full Text] [Related]
20. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]